findmyKOL

Agustin Escalante, MD

Basic profile

The University of Texas at San Antonio Health Science Center

ORCIDNone on fileNPI
RegionSan Antonio, TX · South CentralSpecialtyRheumatologyFocusRheumatology/Immunology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2017Online presenceNot yet checkedPayments2021 onwardNIH funding1999–2011Why? →

Agustin Escalante is a Rheumatology/Immunology physician affiliated with The University of Texas at San Antonio Health Science Center. OpenAlex indexes 74 publications with 5,717 citations (h-index 32).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
74publications

Distinct works indexed by OpenAlex.

5,717citations

Total citations across indexed works.

32h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments
3NIH grants · 1999–2011

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

8300 Floyd Curl Dr
San Antonio, TX 782293931

Telephone

210-450-9000

Provider last certified this registry record 19 Aug 2025.

View the NPPES registry record

Industry payments

4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    41.9%
    TNF inhibitor16.1%
    Enbrel Sureclick47%Humira(Cf) Pen22%Enbrel21%Humira Pen10%
    Part D<11 patients
    Folate Analog Metabolic Inhibitor14.3%
    Methotrexate100%
    Part D49 patients

    + 5 more classes in this area

  • Metabolism & gastrointestinal

    19.5%
    Corticosteroid15.7%
    Prednisone100%
    Part D67 patients
    Aminosalicylate2%
    Sulfasalazine100%
    Part D<11 patients

    + 1 more class in this area

  • Antiparasitic

    19.3%
    Antimalarial19.3%
    Hydroxychloroquine Sulfate100%
    Part D61 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

3 NIH research awards on record, funded 19992011 per NIH RePORTER. The latest:

15 more award records behind the reveal.Reveal →

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”